Pharma consolidates its grip on post-antibody landscape.
Sheridan
Cormac
C
D000818:Animals; D000906:Antibodies / Q000737:chemistry / Q000276:immunology; D001666:Binding Sites, Antibody; D002986:Clinical Trials as Topic; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D006801:Humans; D051379:Mice; D011485:Protein Binding; D014481:United States; D014486:United States Food and Drug Administration
D000906:Antibodies